III

ERA4TB – Closing the gap between early bacterial activity and clinical cure

  • Chair(s):

    Dr. Santiago Ramon Garcia,
    ARAID Investigator, ARAID Foundation/University of Zaragoza, Fac, Medicine Dept, Microbiology, Zaragoza, Spain

    Prof. Oscar Della Pasqua
    Chair Clinical Pharmacology & Therapeutics,University College London, London, United Kingdom

  • Session description:

    Novel in vitro tools to inform pre-clinical and clinical progression of TB combination therapy
    Dr Santiago Ramon Garcia
    ARAID Investigator, ARAID Foundation/ University of Zaragoza, Fac, Medicine Dept, Microbiology, Zaragoza, Spain

    Treatment relapse: interaction between the immune system and anti-tubercular drugs
    Oscar Della Pasqua
    Chair Clinical Pharmacology, University College London, London, United Kingdom

    Selection of companion drugs and dose rationale for combination therapy
    Dr Silvia Grandoni
    Post-doctoral Fellow, National Research Council, Rome, Italy

    Modelling of the immune response and prediction of treatment relapse
    Dr Filippo Castiglione
    Adjunct Professor, Roma Tre University, Rome, Italy

    Understanding drug distribution in lung tissue, lesion and granulomasistribution
    Dr Aris Dokoumetzidis
    Assistant Professor, "Athena" Research and Innovation Center, Athens, Greece

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

05 Jul 2023

Time

1:35 pm - 3:20 pm

Speakers

Leave A Comment

Go to Top